Articles > Newspapers > U.S. Newspapers, Special Interest > U.S. Newswire articles > October 2009

Article: Health Alliance Announces Promising Nine-Month Results from First Ever Outcome-Based Reimbursement Program for Actonel(R) (risedronate sodium) Tablets

Article from:
U.S. Newswire
Article date:
October 29, 2009
Copyright

To: HEALTH EDITORS

Contact: Penny Ransom, Director of Communications of Health Alliance, +1-217-255-4512

URBANA, Ill., Oct. 29 /PRNewswire/ -- Health Alliance Medical Plans, Inc., a leading provider-sponsored health insurer, covering more than 310,000 commercial plan members in Illinois and Iowa, has announced positive outcomes from a nine-month Fracture Protection Program pilot launched in partnership with the makers of Actonel, a prescription drug for the treatment and prevention of postmenopausal osteoporosis.

Through the program with Health Alliance, the makers of Actonel agreed to reimburse a maximum number of non-spinal osteoporotic fractures per 1,000 patients over one year. During ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: Health Alliance Announces First Fracture Protection ...
PR Newswire;  April 14, 2009 ;     700+ words ... ... spinal osteoporotic fractures in women correctly taking Actonel, by proportionally reducing Health Alliance's cost of purchasing Actonel. This Fracture Protection Program puts Health Alliance at the forefront of the nation's healthcare policy ...

Article: Health Alliance Announces Promising Nine-Month ...
PR Newswire;  October 29, 2009 ;     700+ words ... ... program with Health Alliance, the makers of Actonel agreed to reimburse ... trial data for Actonel. Christina Barrington, Health Alliance Pharmacy Director ... correctly taking Actonel, by proportionally reducing Health Alliance's cost of purchasing ...

Article: Health Alliance Announces Promising Nine-Month ...
Women's Health Weekly;  November 12, 2009 ;     700+ words ... ... program with Health Alliance, the makers of Actonel agreed to reimburse ... trial data for Actonel. Christina Barrington, Health Alliance Pharmacy Director ... correctly taking Actonel, by proportionally reducing Health Alliance's cost of purchasing ...

Article: Actonel Significantly Reduced Osteoporotic Fractures in ...
PR Newswire;  February 10, 2003 ;     700+ words ... ... published data show that treatment with 5 mg Actonel(R) (risedronate sodium tablets) daily ... percent, respectively, at one year with Actonel compared with placebo. The analysis of ... that the fracture reduction benefits of Actonel in patients at higher risk of fracture ...

Article: Actonel(R) Provides Low Incidence of Vertebral Fracture in ...
PR Newswire;  June 19, 2003 ;     700+ words ...In a long-term clinical trial of Actonel(R) (risedronate sodium tablets ... safety profile and sustained efficacy of Actonel in the treatment of postmenopausal osteoporosis ... postmenopausal women. One group received Actonel 5 mg daily for 7 years; the other received ...

Article: Actonel Significantly Reduced Moderate and Severe ...
PR Newswire;  September 20, 2002 ;     700+ words ... ... Research (ASBMR) showed that a 5 mg dose of Actonel(R) (risedronate sodium tablets) daily ... analysis combined data from two large Actonel clinical trials, VERT-NA and VERT ... fracture at one year in women who received Actonel or placebo. Fracture severity was determined ...

Article: Actonel significantly reduced fractures in high-risk ...
Health & Medicine Week;  March 10, 2003 ;     700+ words ... ... published data show that treatment with 5 mg Actonel (risedronate sodium tablets) daily reduced ... and 60%, respectively, at 1 year with Actonel compared with placebo. The analysis of ... that the fracture reduction benefits of Actonel in patients at higher risk of fracture ...

Article: Actonel(R) Set to Enter a Billion Dollar Market with ...
PR Newswire;  January 17, 2002 ;     700+ words ... ... Benet and Aventis Pharma/Ajinomoto as Actonel. "We are very pleased about the approval ... Ajinomoto, Takeda and Aventis to offer Actonel's rapid and sustained efficacy and proven ... estimated to suffer from osteoporosis. Actonel's launch this spring is within six months ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives